LAS VEGAS - At the Smart Health Transformation Forum during HIMSS25 here, Matt Cybulsky, healthcare leader for AI, go-to-market and design at Ionian Consulting, discussed forecasting and improving care using technology.
In his talk entitled, "Halcycon Days Ahead: A New Epoch of Forecasting and Improving Care," Cybulsky said that while AI has transformed how we interact, obtain information and...
Silicon Valley giant NVIDIA announced a partnership with the Arc Institute and Stanford University to launch a new foundation model, Evo 2, that understands the genetic code for all domains of life.
The model, which is being touted as the largest publicly available AI model for genomic data, was built using the NVIDIA DGX Cloud platform on Amazon Web Services (AWS) in collaboration with Arc and...
DoseSpot, an electronic prescribing platform that enables providers to send prescriptions directly to a patient's pharmacy from a clinic, is launching DoseSpot Connect – a product suite designed to give patients instant access to pharmacies offering their prescribed medication at the lowest cost.
"Connect is giving patients transparency and choice with their medications that they've never had...
Kauvery Hospital invests in Lifesigns
Lifesigns has received undisclosed funding from Kauvery Hospital Group's investment arm, Healthcare Capital.
The new funds, based on a press statement, will "advance Lifesigns’ AI and predictive algorithm capabilities." The company offers an AI-powered remote patient monitoring system that provides alerts and predictive insights.
Lifesigns is now gearing...
Editors note: This article has been updated with quotes from Walgreens and Everly Health Solutions to MobiHealthNews.
A federal judge in Delaware ruled that Walgreens must pay $987 million as part of an arbitration award won by telemedicine provider PWNHealth, which also does business as Everly Health Solutions.
U.S. District Judge Richard Andrews dismissed Walgreens' argument that the...
Investment firm General Catalyst has announced the launch of the EU AI Champions Initiative, aimed at advancing Europe's AI momentum by coordinating efforts that include technology, industry, capital and policy.
The initiative brings together more than 60 European companies ranging from startups to established incumbents.
Backers of the initiative include pharma giant Siemens, and more than 20...
Zest Health, a virtual care company that treats patients with inflammatory skin diseases, announced it raised $14 million in seeding funding.
The round was led by Roivant Health, which incubated and participated in the investment.
WHAT IT DOES
Patients sign up for Zest's services via its virtual platform and are offered individualized, reactive care.
Zest’s virtual, high-touch method uses...
Cognizant, an IT consulting firm, announced it is expanding its existing relationship with biopharmaceutical company Gilead Sciences to deliver better cost leadership and productivity enhancement for Gilead, while extracting greater value from the existing relationship.
Harnessing the power of machine learning and generative AI within an agentic framework, the work deals with multiple use cases...
Absci, a data-first generative AI drug-creation company, is partnering with AMD, a semiconductor company, to deploy AMD Instinct accelerators and ROCm software to power vital AI drug-discovery workloads, as well as Absci's advanced De Novo antibody-design models.
In addition, AMD is making a $20 million investment in Absci. The investment will be structured as a private investment in public...
Drug discovery startup Insilico Medicine and Italian pharmaceutical company Menarini Group announced their second licensing agreement, which targets unmet needs in oncology with a novel AI-discovered preclinical asset.
The agreement grants Stemline Therapeutics, a subsidiary of Menarini, global rights to develop and commercialize a selective small molecule inhibitor with broad antitumor activity...
8e14.jpg "Person sitting at a computer while in a dark room")
